Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gemeinschaftskrankenhaus Havelhöhe provides acute hospital services with an integrative approach combining conventional guideline-based medicine with complementary anthroposophic therapies. It serves as an academic teaching hospital for Charité – Universitätsmedizin Berlin. The institution participates in multi-center clinical trials across various phases and conducts regular research projects to evaluate its integrative methods.
Patient satisfaction rates are high (~90%), attributed to the unique blend of standard medical care with creative/artistic therapies and personalized support.
No proprietary drug development pipeline; focus on patient care delivery.
Research activities include participation in multi-center phase I–IV studies.
Clinical results pertain to patient outcomes/satisfaction rather than investigational drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gemeinschaftskrankenhaus Havelhöhe.